cbdMD, Inc. (YCBD)
Stock Price:
$2.39 USD
-0.04 (-1.65%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
122.69M |
| Revenue (ttm) |
37.10M |
| Net Income (ttm) |
11.29M |
| Shares Out |
51.34M |
| EPS (ttm) |
0.35 |
| PE Ratio |
6.83 |
| Forward PE |
476.19 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Jul 10, 2020 |
| Last Price |
$2.39 |
| Previous Close |
$2.43 |
| Change ($) |
-0.04 |
| Change (%) |
-1.65% |
| Day's Open |
2.43 |
| Day's Range |
2.32 - 2.53 |
| Day's Volume |
1,115,964 |
| 52-Week Range |
0.50 - 5.35 |
More Stats
| Market Cap |
122.69M |
| Enterprise Value |
115.80M |
| Earnings Date (est) |
Aug 12, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
51.34M |
| Float |
36.02M |
| EPS (basic) |
1.08 |
| EPS (diluted) |
0.35 |
| FCF / Share |
-0.63 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
14.64% |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
1.67M |
| Short Ratio |
0.42 |
| Short % of Float |
4.76% |
| Beta |
n/a |
| PE Ratio |
6.83 |
| Forward PE |
476.19 |
| P/FCF Ratio |
n/a |
| PS Ratio |
3.31 |
| PB Ratio |
1.30 |
| Revenue |
37.10M |
| Operating Income |
-52.67M |
| Net Income |
11.29M |
| Free Cash Flow |
-22.95M |
| Net Cash |
6.89M |
| Net Cash / Share |
0.13 |
| Gross Margin |
39.13% |
| Operating Margin |
-141.98% |
| Profit Margin |
30.70% |
| FCF Margin |
-61.88% |
| ROA |
-13.93% |
| ROE |
38.79% |
| ROIC |
47.60% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (3)
| Buy |
2 |
| Overweight |
0 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$4.27*
(78.66% upside)
Low
1.80
Current: 2.39
High
8.00
Target: 4.27
*Average 12-month price target from 3 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | 23.65 | 0.46 | 4.47 | 2.03 |
| Revenue Growth | 5051.82% | -89.74% | 120.27% | - |
| Gross Profit | 14.51 | 0.36 | 3.12 | 0.41 |
| Operating Income | -44.11 | -1.80 | -0.24 | -3.73 |
| Net Income | -50.43 | -0.41 | -1.74 | -3.36 |
| Shares Outstanding | 17.89 | 7.74 | 4.52 | 2.98 |
| Earnings Per Share | - | - | -0.38 | -1.13 |
| Operating Cash Flow | -15.38 | -5.57 | -2.33 | -2.90 |
| Capital Expenditures | -1.20 | -0.02 | -0.01 | -0.13 |
| Free Cash Flow | -16.58 | -5.60 | -2.34 | -3.02 |
| Cash & Equivalents | 5.50 | 7.11 | 1.42 | 0.03 |
| Total Debt | - | - | - | 0.80 |
| Net Cash / Debt | 5.50 | 7.11 | 1.42 | -0.76 |
| Assets | 94.52 | 15.02 | 7.07 | 1.62 |
| Liabilities | 56.91 | 1.00 | 1.92 | 1.92 |
| Book Value | 37.60 | 12.61 | 4.21 | 0.36 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
cbdMD, Inc. |
| Country |
United States |
| Employees |
182 |
| CEO |
Martin A. Sumichrast / Raymond Scott Coffman |
Stock Information
| Ticker Symbol |
YCBD |
| Stock Exchange |
NYSE American |
| Sector |
Healthcare |
| Industry |
Drug Manufacturers—Specialty & Generic |
| Unique Identifier |
NYSEAMERICAN: YCBD |
Description
cbdMD, Inc. produces and distributes various cannibidiol (CBD) products. It owns and operates the consumer hemp-based CBD brand, cbdMD. The company's product categories include CBD tinctures, capsules, gummies, bath bombs, topical creams, and animal treats and oils. It also offers pet related CBD products under the Paw CBD brand name. The company distributes its products through an e-commerce Website, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is headquartered in Charlotte, North Carolina.